Medicare Enrolled
Florida Board Action on Record
The Florida Department of Health has flagged this practitioner's license with a board action.
Verify on FL DOH →
Dr. Thomas Digeronimo, M.D.
Neurology · Plant City, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Digeronimo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Digeronimo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Digeronimo
Dr. Thomas Digeronimo is a neurology specialist in Plant City, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Digeronimo performed 7,029 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Digeronimo received a total of $22,034 from 84 pharmaceutical and/or device companies across 1266 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Digeronimo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in FL
$22,034 industry payments
Florida License Status
FL DOH · MQA1
Active license
Yes
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 54874 | Clear | January 31, 2027 | ⚠ |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗7,029
Medicare services
Top 13% in FL for neurology
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,600 | $5 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
640 | $90 | $258 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
296 | $76 | $173 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
98 | $0 | $1 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
86 | $155 | $323 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $63 | $174 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $115 | $404 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
61 | $100 | $203 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
30 | $12 | $35 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
24 | $265 | $882 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
16 | $226 | $439 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
13 | $46 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$22,034
Total received (2018-2024)
Avg $3,148/year across 7 years
Top 15% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,266
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,354
2023
$2,768
2022
$3,427
2021
$4,226
2020
$2,889
2019
$2,773
2018
$2,597
Payments by company (2024)
UCB, Inc.
$876
ABBVIE INC.
$407
PFIZER INC.
$342
Novartis Pharmaceuticals Corporation
$239
Eisai Inc.
$227
Teva Pharmaceuticals USA, Inc.
$224
Celgene Corporation
$212
Lilly USA, LLC
$113
MITSUBISHI TANABE PHARMA AMERICA, INC.
$112
Sumitomo Pharma America, Inc.
$88
Neurelis, Inc.
$80
Lundbeck LLC
$74
Otsuka America Pharmaceutical, Inc.
$62
LivaNova USA, Inc.
$56
Kyowa Kirin, Inc.
$45
Amgen Inc.
$36
E.R. Squibb & Sons, L.L.C.
$34
ARGENX US, INC.
$28
Neurocrine Biosciences, Inc.
$27
Acorda Therapeutics, Inc
$20
Novo Nordisk Inc
$18
EMD Serono, Inc.
$17
Alnylam Pharmaceuticals Inc.
$16
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,549
Amgen Inc.
$1,578
Teva Pharmaceuticals USA, Inc.
$1,478
Novartis Pharmaceuticals Corporation
$1,339
PFIZER INC.
$1,139
EMD Serono, Inc.
$929
ABBVIE INC.
$719
Avanir Pharmaceuticals, Inc.
$684
Celgene Corporation
$639
AbbVie Inc.
$589
Biogen, Inc.
$575
Allergan, Inc.
$574
Eisai Inc.
$491
UPSHER-SMITH LABORATORIES LLC
$470
Lilly USA, LLC
$407
Kyowa Kirin, Inc.
$368
Biohaven Pharmaceuticals, Inc.
$352
Neurelis, Inc.
$330
Sunovion Pharmaceuticals Inc.
$322
Janssen Pharmaceuticals, Inc
$320
Allergan Inc.
$311
Biohaven Pharmaceutical Holding Company Ltd.
$309
AQUESTIVE THERAPEUTICS, INC.
$298
Collegium Pharmaceutical, Inc.
$281
Lundbeck LLC
$279
Upsher-Smith Laboratories LLC
$264
Genentech USA, Inc.
$257
Otsuka America Pharmaceutical, Inc.
$253
Acorda Therapeutics, Inc
$244
SK Life Science, Inc.
$235
Neurocrine Biosciences, Inc.
$226
EISAI INC.
$200
JAZZ PHARMACEUTICALS INC.
$190
SCILEX PHARMACEUTICALS INC.
$188
Daiichi Sankyo Inc.
$166
Scilex Pharmaceuticals Inc.
$157
Amneal Pharmaceuticals LLC
$142
MITSUBISHI TANABE PHARMA AMERICA, INC.
$134
ARGENX US, INC.
$129
GENZYME CORPORATION
$121
Greenwich Biosciences, Inc.
$116
E.R. Squibb & Sons, L.L.C.
$116
Supernus Pharmaceuticals, Inc.
$112
GE HEALTHCARE
$105
CSL Behring
$104
ACADIA Pharmaceuticals Inc
$100
US WorldMeds, LLC
$90
Sumitomo Pharma America, Inc.
$88
Harmony Biosciences LLC
$85
Alexion Pharmaceuticals, Inc.
$82
Neuronetics, Inc.
$75
GE Healthcare
$59
Jazz Pharmaceuticals Inc.
$59
LivaNova USA, Inc.
$56
Merck Sharp & Dohme Corporation
$50
Takeda Pharmaceuticals U.S.A., Inc.
$44
Zyla Life Sciences, Inc.
$30
HARMONY BIOSCIENCES LLC
$25
Banner Life Sciences, LLC
$24
Mallinckrodt Hospital Products Inc.
$21
Vertical Pharmaceuticals, LLC
$19
AbbVie, Inc.
$19
Averitas Pharma Inc.
$19
Assertio Therapeutics, Inc.
$19
Novo Nordisk Inc
$18
IDORSIA PHARMACEUTICALS US INC
$17
Pernix Therapeutics Holdings, Inc.
$17
Avion Pharmaceuticals
$16
Alnylam Pharmaceuticals Inc.
$16
Xeris Pharmaceuticals, Inc.
$16
Corium, Inc.
$16
BioDelivery Sciences International, Inc.
$16
Corium, LLC
$15
Shire North American Group Inc
$14
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Promius Pharma LLC
$14
Nevro Corp.
$13
Adamas Pharmaceuticals, Inc.
$12
IMPEL PHARMACEUTICALS INC.
$12
Arbor Pharmaceuticals, Inc.
$12
Metacel Pharmaceuticals LLC
$12
Mitsubishi Tanabe Pharma America, Inc.
$11
Neos Therapeutics, LP
$11
Grifols USA, LLC
$11
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adzenys XR-ODT · Aimovig · Austedo XR · Azstarys · BAFIERTAM · BELBUCA · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · Briviact · CHANTIX · COMIRNATY · COPAXONE · Cambia · DIVIGEL · Dhivy · ELYXYB - celecoxib · EMBEDA · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Fycompa · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Morphabond ER · Movantik · NAMZARIC · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · Omnia · Ongentys · Ozempic · Ozobax · PAXLOVID · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XTAMPZA · XYREM · Xadago · Xtampza ER · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
125
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
SOUTH FLORIDA BAPTIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Digeronimo is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Digeronimo experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Digeronimo performed 5,600 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Digeronimo receive payments from pharmaceutical companies?
Yes. Dr. Digeronimo received a total of $22,034 from 84 companies across 1,266 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Digeronimo's costs compare to other neurologists in Plant City?
Dr. Digeronimo's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Digeronimo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Plant City
Browse neurologists in Plant City ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology